Thyroid hormone production increases during pregnancy. Thyroid dysfunction is common during pregnancy, and both hyperthyroidism and hypothyroidism are associated with increased risk of adverse pregnancy and perinatal outcomes. Accurate assessment of thyroid status and management of thyroid dysfunction in pregnant women are crucial to optimize maternal-fetal outcomes.
The guideline development process was sponsored by the ATA as a planned revision of guidelines published in 2011.1 The ATA appointed a task force of specialists in diverse areas. Standardized data collection forms were used and a literature search was performed for each topic, relevant literature appraised, and recommendations generated. External peer review was obtained on key recommendations. The guidelines were funded by the ATA, but task force members received no funding from the ATA or industry (Table 1). Conflicts of interest were reviewed initially, yearly, and on completion of the guideline. One committee member with a potential conflict recused himself from review of relevant guideline sections.
Dickens LT, Cifu AS, Cohen RN. Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum Period. JAMA. Published online May 03, 2019321(19):1928–1929. doi:10.1001/jama.2019.5321
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: